Sign in

CIK 0001756262

  • Large accelerated filer

TransMedics Group, Inc.

Sign in to watch
Ticker
TMDX
Exchange
Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
FY end
Dec 31
Incorporated
MA
Entity type
Operating
Phone
+1 978-552-0900
Business address
200 MINUTEMAN ROAD, ANDOVER, MA, 01810
Open-market buys, last 90 days
$109,058
in 1 filing
Open-market sales, last 90 days
$385,464
in 1 filing

Net −$276,406. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. TOBIN JAMES R −$385K Director sold 58% of stake
  2. Weill David +$109K Director 1 filing

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-01-17 Carey John F VP of Operations Sale −449 $63.70 $29K 14,234
2023-01-17 Carey John F VP of Operations Sale −114 $64.30 $7K 14,120
2023-01-17 Carey John F VP of Operations Exercise or conversion · Stock Option (Right to Buy) −1,410 13,590
2023-01-13 Khayal Tamer I Chief Commercial Officer Exercise or conversion +5,900 $16.00 $94K 7,200
2023-01-13 Khayal Tamer I Chief Commercial Officer Sale −5,900 $60.20 $355K 1,300
2023-01-13 Khayal Tamer I Chief Commercial Officer Exercise or conversion · Stock Option (Right to Buy) −5,900 54,285
2023-01-03 Khayal Tamer I Chief Commercial Officer Exercise or conversion +4,100 $16.00 $66K 5,400
2023-01-03 Khayal Tamer I Chief Commercial Officer Sale −900 $60.93 $55K 4,500
2023-01-03 Khayal Tamer I Chief Commercial Officer Sale −2,700 $61.99 $167K 1,800
2023-01-03 Khayal Tamer I Chief Commercial Officer Sale −500 $62.79 $31K 1,300
2023-01-03 Khayal Tamer I Chief Commercial Officer Exercise or conversion · Stock Option (Right to Buy) −4,100 60,185
2022-12-15 DAMME LAURA VP, Clinical Affairs Exercise or conversion +250 $38.46 $10K 250
2022-12-15 DAMME LAURA VP, Clinical Affairs Sale −250 $60.02 $15K 0
2022-12-15 DAMME LAURA VP, Clinical Affairs Exercise or conversion +4,740 $38.46 $182K 4,740
2022-12-15 DAMME LAURA VP, Clinical Affairs Sale −4,740 $58.96 $279K 0
2022-12-15 DAMME LAURA VP, Clinical Affairs Exercise or conversion · Stock Option (Right to Buy) −250 18,803
2022-12-15 DAMME LAURA VP, Clinical Affairs Exercise or conversion · Stock Option (Right to Buy) −4,740 14,063
2022-12-14 DAMME LAURA VP, Clinical Affairs Exercise or conversion +5,947 $38.46 $229K 5,947
2022-12-14 DAMME LAURA VP, Clinical Affairs Sale −5,947 $62.43 $371K 0
2022-12-14 DAMME LAURA VP, Clinical Affairs Exercise or conversion · Stock Option (Right to Buy) −5,947 19,053

Page 31 of 38 · 744 trades